Comprehensive Guide • Updated March 2026

Every Ozempic Alternative Compared

By , HighPeptides Editor

Ozempic alternatives range from FDA-approved options to investigational compounds with distinct efficacy profiles. Semaglutide (Wegovy) produces average 14.9% weight loss; tirzepatide (Zepbound) achieves 22.5% in SURMOUNT-1; and the investigational retatrutide reached 28.7% — the highest of any obesity drug tested to date. This comparison covers efficacy, cost, availability, and side effects across all categories.

0%
Retatrutide Weight Loss
(TRIUMPH-4 Phase 3)
0%
Tirzepatide Weight Loss
(SURMOUNT-1)
0%
Semaglutide Weight Loss
(STEP 1)
📋 On this page
  1. Why People Look for Ozempic Alternatives
  2. Weight Loss by Drug — Head to Head
  3. FDA-Approved GLP-1 Alternatives
  4. Investigational & Emerging Compounds
  5. Compounded Semaglutide
  6. Natural & OTC Alternatives
  7. Decision Matrix: Every Option Compared
  8. Side Effects Across GLP-1 Drugs
  9. Choosing the Right Alternative
  10. Related HighPeptides Resources
  11. 🛒 Weight Loss Journey Essentials

The Problem

Why People Look for Ozempic Alternatives

Ozempic and Wegovy changed weight loss forever — but they're not perfect for everyone. Here's why millions of people are searching for alternatives.

💰

Prohibitive Cost

$1,000–$1,350/month without insurance. Many plans don't cover weight loss medications, and prior authorization denials are common.

🤢

Side Effects

Nausea, vomiting, and GI distress affect 15–25% of users. Some people can't tolerate semaglutide but respond well to other GLP-1 drugs.

📦

Supply Shortages

Demand has consistently outstripped supply since 2022. Certain doses remain intermittently unavailable, disrupting treatment continuity.

🔬

Better Options Exist

Newer drugs like tirzepatide achieve ~50% more weight loss than semaglutide. Next-gen compounds in trials show even greater efficacy.

Clinical Trial Data

Weight Loss by Drug — Head to Head

Maximum average body weight reduction from landmark clinical trials. Bars animate as you scroll. All figures represent placebo-adjusted or total weight change at study endpoint.

Investigational (Not Yet FDA-Approved)
Retatrutide (Triple Agonist) ★
TRIUMPH-4 Phase 3 • GIP + GLP-1 + Glucagon • Eli Lilly
−28.7%
Survodutide
Phase 3 • GLP-1 + Glucagon • Boehringer Ingelheim
−19%
FDA-Approved for Weight Loss
Tirzepatide (Zepbound)
SURMOUNT-1 • Dual GIP + GLP-1 • Eli Lilly
−22.5%
Semaglutide 2.4mg (Wegovy)
STEP 1 • GLP-1 only • Novo Nordisk
−14.9%
Liraglutide (Saxenda)
SCALE • GLP-1 only (older gen) • Novo Nordisk
−8.0%
Oral Options
Orforglipron (oral GLP-1)
Phase 3 • Oral pill • Eli Lilly
−14.7%
Amycretin (oral dual agonist)
Phase 2 • Oral pill • Novo Nordisk
−13.1%
Rybelsus (oral semaglutide)
FDA-Approved for T2D • Oral pill • Novo Nordisk
−4.4%
⚠️
Cross-trial comparison caveat: These numbers come from different clinical trials with different populations, durations, and protocols. Direct comparison is useful for context but inherently imprecise. Only head-to-head trials provide definitive answers.

Available Now

FDA-Approved GLP-1 Alternatives

These drugs are currently available by prescription. Tirzepatide is the standout — achieving significantly more weight loss than semaglutide through its dual-agonist mechanism.

Tirzepatide
Mounjaro (T2D) / Zepbound (Obesity) • Eli Lilly
Mechanism Dual agonist (GIP + GLP-1)
Weight Loss Up to 22.5% (SURMOUNT-1, 72wk)
FDA Status ✓ FDA Approved
Route Weekly injection
Cost ~$1,060/mo (list price)
Key Advantage ~50% more weight loss than semaglutide; dual mechanism may reduce GI side effects
Liraglutide
Saxenda (Obesity) / Victoza (T2D) • Novo Nordisk
Mechanism GLP-1 agonist (older generation)
Weight Loss ~8% (SCALE trial, 56wk)
FDA Status ✓ FDA Approved
Route Daily injection
Cost ~$1,350/mo (list price)
Key Advantage Longest safety track record; well-established; some insurance plans cover it
Oral Semaglutide
Rybelsus • Novo Nordisk
Mechanism GLP-1 agonist (pill form)
Weight Loss ~4.4% at 14mg (PIONEER trials)
FDA Status ✓ Approved (T2D)
Route Daily oral tablet
Cost ~$936/mo (list price)
Key Advantage No injections; same compound as Ozempic; FDA-approved for diabetes (off-label for weight loss)

Coming Soon

Investigational & Emerging Compounds

The next generation of weight loss drugs in clinical trials. These aren't available yet but represent where the field is heading — and they may make today's options obsolete.

Retatrutide
Eli Lilly • LY3437943
Phase 3

The most effective obesity drug ever tested. Retatrutide is a triple agonist targeting GIP, GLP-1, and glucagon receptors simultaneously. The glucagon component drives direct fat burning and energy expenditure — a mechanism no approved drug uses. Phase 3 TRIUMPH-4 data showed 28.7% average weight loss.

28.7%
Max Weight Loss
Triple
Agonist (3 targets)
Weekly
Injection
2026–27
Expected Approval
Survodutide
Boehringer Ingelheim
Phase 3

A dual GLP-1/glucagon agonist (different dual combo than tirzepatide). Phase 2 data showed ~19% weight loss at 46 weeks. Also being studied for MASH/NAFLD (fatty liver disease), where it showed significant liver fat reduction — potentially a two-for-one drug.

~19%
Weight Loss (Ph2)
Dual
GLP-1 + Glucagon
MASH
Also Studied For
Orforglipron
Eli Lilly
Phase 3

A non-peptide oral GLP-1 agonist — meaning it's a pill, not an injection, and doesn't need to be taken on an empty stomach like Rybelsus. Phase 2 showed ~14.7% weight loss at 36 weeks. Could be a game-changer for the injection-averse.

14.7%
Weight Loss (Ph2)
Oral
Daily Pill
No
Fasting Required
Amycretin
Novo Nordisk
Phase 2

Novo Nordisk's answer to the oral GLP-1 challenge. Amycretin is a dual amylin/GLP-1 agonist in pill form. Early Phase 1/2 data showed ~13.1% weight loss at just 12 weeks — suggesting a potentially steep weight loss curve. Still early stage.

13.1%
Weight Loss (12wk)
Oral
Daily Pill
Dual
Amylin + GLP-1

The Budget Option

Compounded Semaglutide

Same active ingredient as Ozempic, prescribed by a physician, made by compounding pharmacies — at a fraction of the brand-name cost.

How It Works

When the FDA classifies a drug as being in shortage, compounding pharmacies are legally permitted to produce copies of that drug. Semaglutide has been classified as in shortage since 2022 due to unprecedented demand.

Compounded semaglutide contains the same active ingredient as Ozempic and Wegovy but is produced by compounding pharmacies rather than Novo Nordisk. It requires a physician prescription and is available through telehealth platforms and prescribing physicians.

Category 1 Reclassification

In early 2025, the FDA reclassified semaglutide under Category 1 of its shortage framework. This means compounding pharmacies can continue producing semaglutide under specific conditions, but the regulatory landscape is evolving. Patients should verify current availability with their prescriber.

$1,000+
Brand Ozempic/Wegovy
(monthly, no insurance)
$150–500
Compounded Semaglutide
(monthly, telehealth)

⚠️ Important Considerations

Compounded semaglutide is not an FDA-approved product. Quality varies between pharmacies. Look for pharmacies that provide certificates of analysis (COA) and third-party testing. The regulatory status may change — always verify with your prescriber.

💡 The Same Drug, Different Source

Compounded semaglutide works the same way as Ozempic because it is the same molecule. The difference is manufacturing oversight. Brand-name products go through FDA manufacturing inspections; compounded products are regulated by state pharmacy boards.

No Prescription Required

Natural & OTC Alternatives

Supplements, lifestyle changes, and non-prescription approaches. We'll be honest: none of these come close to prescription GLP-1 drugs, but they have their place.

🌿
Berberine
Called "nature's Ozempic" on TikTok, berberine activates AMPK and modestly improves insulin sensitivity. Research shows small effects on blood sugar and cholesterol, but weight loss averages only 2–5 lbs over several months — a far cry from GLP-1 drugs.
~2–5 lbs weight loss
🥦
High-Fiber Diet
Fiber (especially viscous/soluble) slows gastric emptying and promotes satiety — mimicking one of GLP-1's mechanisms. Studies show high-fiber diets can reduce caloric intake by 10% and support 3–5% weight loss. Psyllium husk, glucomannan, and beans are top sources.
~3–5% weight loss
🥩
High-Protein Diet
Protein is the most satiating macronutrient. Targeting 30g+ per meal increases GLP-1 and PYY release naturally, reduces hunger, and preserves lean mass during weight loss. Combined with resistance training, this is the foundation of sustainable weight management.
5–10% with calorie deficit
🏋️
Structured Exercise
Resistance training + zone 2 cardio improves insulin sensitivity, preserves muscle during weight loss, and supports 5–8% weight reduction when combined with dietary changes. Exercise also mitigates muscle loss that can occur with GLP-1 drugs alone.
5–8% with diet changes
🎯
Reality check: No natural supplement or lifestyle change matches the 15–28% weight loss seen with prescription GLP-1 drugs. Berberine, fiber, and protein are good for you and worth incorporating into any weight management plan — but if you're comparing efficacy to Ozempic, they operate in a completely different league. The best approach for many people combines pharmacotherapy with lifestyle optimization.

Side-by-Side

Decision Matrix: Every Option Compared

All alternatives in one view. Scroll horizontally on mobile. Sort by what matters most to you — efficacy, cost, or availability.

Drug / Option Mechanism Efficacy Monthly Cost Route Availability Key Side Effects
Tirzepatide
Zepbound		 Dual GIP + GLP-1 22.5% $1,060 Weekly injection Available now Nausea, diarrhea, constipation
Semaglutide
Wegovy/Ozempic		 GLP-1 only 14.9% $1,000–1,350 Weekly injection Available now Nausea, vomiting, diarrhea
Liraglutide
Saxenda		 GLP-1 only (older) 8.0% $1,350 Daily injection Available now Nausea, headache, hypoglycemia
Rybelsus
Oral semaglutide		 GLP-1 (oral) 4.4% $936 Daily pill Approved (T2D) Nausea, abdominal pain
Retatrutide
Triple agonist		 GIP + GLP-1 + GCG 28.7% TBD Weekly injection Phase 3 (2026–27) Nausea, diarrhea, vomiting
Survodutide GLP-1 + Glucagon ~19% TBD Weekly injection Phase 3 GI effects, liver enzyme changes
Orforglipron Non-peptide GLP-1 (oral) 14.7% TBD Daily pill Phase 3 Nausea, vomiting, diarrhea
Amycretin Amylin + GLP-1 (oral) 13.1%* TBD Daily pill Phase 2 GI effects (early data)
Compounded Semaglutide GLP-1 only ~14.9% $150–500 Weekly injection Physician Rx Same as brand semaglutide
Berberine AMPK activator 2–5 lbs $15–30 Oral supplement OTC GI discomfort, drug interactions
Diet + Exercise Lifestyle 5–10% Free N/A Always available Requires sustained effort

* Amycretin 13.1% was at 12 weeks only; longer-term data pending. All other figures are at study endpoint (36–72 weeks).

Safety Profile

Side Effects Across GLP-1 Drugs

Most GLP-1 drugs share similar side effects because they work through related pathways. Rates shown are typical across the drug class at therapeutic doses.

Nausea15–25%
Diarrhea12–22%
Vomiting5–13%
Constipation8–12%
Decreased Appetite6–10%
Injection Site Reactions3–7%

💡 Titration Reduces Side Effects

Starting at the lowest dose and gradually increasing over 4–16 weeks dramatically reduces GI side effects. Most nausea and vomiting occurs during the first few weeks of each dose increase and improves with time.

⚠️ Rare but Serious Risks

All GLP-1 drugs carry rare risks of pancreatitis, gallbladder events, and potential thyroid C-cell tumors (seen in rodents, unclear in humans). These are listed as boxed warnings. Always discuss personal risk factors with your physician.

✅ Muscle Loss Mitigation

GLP-1 drugs cause weight loss from both fat and lean mass. Resistance training (2–3x/week) and adequate protein intake (1g/lb lean mass) can significantly preserve muscle during treatment.

Bottom Line

Choosing the Right Alternative

What matters most for different situations.

✅ Clear Winners by Situation
  • Best efficacy (available now): Tirzepatide (Zepbound) — 22.5% weight loss, FDA-approved, dual mechanism
  • Best value: Compounded semaglutide — same drug as Ozempic at 70–85% less cost
  • Hate injections: Rybelsus today; orforglipron when approved
  • Maximum weight loss (future): Retatrutide — 28.7% in trials, potentially available 2026–2027
  • Supplement stack: Berberine + fiber + protein + exercise — modest but real benefits, no prescription needed
⚠️ Important Caveats
  • Individual response varies significantly — some people lose more on semaglutide than others do on tirzepatide
  • Insurance coverage often dictates the "best" option more than clinical efficacy does
  • All GLP-1 drugs require ongoing use — weight typically rebounds after stopping
  • Compounded semaglutide availability depends on FDA shortage classifications, which can change
  • Emerging drugs may look impressive in trials but haven't been tested in real-world populations at scale

Dive Deeper

Research breakdowns, calculators, and comparison tools for every GLP-1 drug mentioned above.

💉
Semaglutide Calculator
Dosing & reconstitution guide
→ ⚗️
Tirzepatide Calculator
Mounjaro/Zepbound dosing
→ 🧬
Retatrutide Calculator
Triple agonist dosing guide
→ 🏆
Retatrutide Trial Data
Full Phase 2 results visualized
→ 📊
Tirzepatide Trial Data
SURMOUNT-1 results breakdown
→ 📉
Semaglutide Trial Data
STEP 1 results breakdown
→ 🩸
GLP-1s & Insulin Resistance
Metabolic benefits beyond weight
→ ⚔️
Semaglutide vs Tirzepatide
Head-to-head comparison
→ ⚖️
Semaglutide vs Retatrutide
Current vs next-gen
→ 📈
GLP-1 Weight Loss Plotter
Interactive projection tool
→ 💊
Oral vs Injectable Peptides
Why delivery method matters
→ 🎙️
Huberman on Peptides
Podcast episode breakdown
→

Recommended

🛒 Weight Loss Journey Essentials

Track your progress and support your protocol with these essentials.

⚖️ Smart Body Scale Bluetooth-connected scale with body composition tracking — weight, BMI, body fat %, lean mass. 🍱 Meal Prep Containers Glass portion-control containers for high-protein meal prepping on GLP-1 therapy. 📏 Body Measuring Tape Track waist, hips, and body measurements — often a better progress metric than the scale. 🥤 Protein Powder Whey isolate for hitting 30g+ protein per meal — critical for preserving muscle on GLP-1s.

Affiliate links help support HighPeptides at no extra cost to you.

📚

Want the Complete Protocol Guide?

Dosing schedules, interaction warnings, and cycle protocols for 50+ compounds — all in one place.


Get the Guide →

⚕️ Medical Disclaimer: This page is for educational and informational purposes only. It is not medical advice and should not be used as a substitute for professional medical consultation. All medications discussed carry risks and require physician oversight. Never start, stop, or change medications without consulting a qualified healthcare provider. Weight loss results vary by individual. Data sourced from published peer-reviewed clinical trials (STEP, SURMOUNT, TRIUMPH, SCALE, PIONEER). Always verify current drug availability and pricing with your pharmacy or prescriber.

HighPeptides · Research Library · © 2026